Treatment of stage I hypertension and development of renal dysfunction

被引：4

作者：

Bakris, GL ^{[1
]}

机构：

[1] Rush Univ, Rush Presbyterian St Lukes Med Ctr, Hypertens Clin Res Ctr, Dept Prevent Med, Chicago, IL 60612 USA

来源：

关键词：

stage; 1; hypertension; renal dysfunction;

D O I：

10.1038/sj.jhh.1001135

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：81 / 84

页数：4

共 26 条

[1] Proteinuria as a mediator of tubulointerstitial injury
Abbate, M
Remuzzi, G
[J]. KIDNEY & BLOOD PRESSURE RESEARCH, 1999, 22 (1-2) : 37 - 46
[2] Agodoa Lawrence, 1998, Ethnicity and Disease, V8, P249
[3] Bakris G L, 1996, Curr Opin Nephrol Hypertens, V5, P219, DOI 10.1097/00041552-199605000-00006
[4] Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern?
Bakris, GL
Weir, MR
[J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (05) : 685 - 693
[5] Preserving renal function in adults with hypertension and diabetes: A consensus approach
Bakris, GL
Williams, M
Dworkin, L
Elliott, WJ
Epstein, M
Toto, R
Tuttle, K
Douglas, J
Hsueh, W
Sowers, J
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) : 646 - 661
[6] Black HR, 1997, ARCH INTERN MED, V157, P2413
[7] Estacio RO, 2000, DIABETES CARE, V23, pB54
[8] Feldman R D, 1999, Can J Cardiol, V15 Suppl G, p57G
[9] Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) Trial
Fogo, A
Breyer, JA
Smith, MC
Cleveland, WH
Agodoa, L
Kirk, KA
Glassock, R
Faulkner, M
Kopple, JD
Massry, SG
Grim, C
Randall, OS
Toto, RD
Whelton, P
Wright, JT
[J]. KIDNEY INTERNATIONAL, 1997, 51 (01) : 244 - 252
[10] GANSEVOORT RT, 1995, NEPHROL DIAL TRANSPL, V10, P1963